Align slips as brokerage downgrades rating to 'in line' over slowing demand
ALGN•Align Technology shares fell 3% premarket after Evercore ISI cut its rating to “in line” from “outperform,” citing slowing demand and potential China procurement headwinds in 2027.
1. Demand concerns weigh
Evercore ISI said a weakening consumer backdrop and a sharp deceleration in September demand indicators made it more cautious on Align’s earnings outlook. The brokerage said the dental market had meaningfully weakened in the third quarter and that worsening consumer conditions raised the risk of affecting Invisalign demand.
2. China headwinds flagged
Evercore also cited potential headwinds from China’s volume-based procurement program in 2027, saying they could make Align’s path more difficult despite signs of an internal turnaround. Invisalign generated about $3.2 billion of Align’s $4.0 billion in revenue in 2025.
